Clinical Trial: Effect of Dalfampridine in Patients With Hereditary Spastic Paraplegia
Study Status: Completed
Recruit Status: Completed
Condition: Hereditary Spastic Paraplegia
Study Type: Interventional
Official Title: Effect of Dalfampridine in Patients With Hereditary Spastic Paraplegia
Brief Summary:
There are limited but encouraging results supporting the use of dalfampridine in patients with hereditary spastic paraplegia. The investigators aimed to investigate the effects of dalfampridine on walking speed, muscle length, spasticity, functional strength, and functional mobility in patients with hereditary spastic paraplegia. In this triple-blinded, randomized, placebo-controlled trial, 4 patients with hereditary spastic paraplegia received dalfampridine (10 mg twice daily) plus physiotherapy (2 times per…
Read more